Preventive effects of a natural anti-inflammatory agent, astragaloside IV, on ischemic acute kidney injury in rats

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Tan, Shufeng ^a   Wang, Guofu ^b   Guo, Yongping ^a   Gui, Dingkun ^a   Wang, Niansong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b ZHEJIANG HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASTRAGALOSIDE IV; CREATININE; CYSTATIN C; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UREA;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; KIDNEY ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR DOWN REGULATION; RENAL PROTECTION; UREA BLOOD LEVEL;

EID: 84880159814     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/284025     Document Type: Article

References (50)

1. Levy E. M., Viscoli C. M., Horwitz R. I., The effect of acute renal failure on mortality: a cohort analysis. The Journal of the American Medical Association 1996 275 19 1489 1494 2-s2.0-0029925567 10.1001/jama.275.19.1489 (Pubitemid 26140761)
2. Chertow G. M., Burdick E., Honour M., Bonventre J. V., Bates D. W., Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. Journal of the American Society of Nephrology 2005 16 11 3365 3370 2-s2.0-33644874086 10.1681/ASN.2004090740 (Pubitemid 46179340)
3. Schiffl H., Lang S. M., Fischer R., Daily hemodialysis and the outcome of acute renal failure. The New England Journal of Medicine 2002 346 5 305 310 2-s2.0-0037204183 10.1056/NEJMoa010877 (Pubitemid 34438837)
4. Thadhani R., Pascual M., Bonventre J. V., Acute renal failure. The New England Journal of Medicine 1996 334 22 1448 1460 2-s2.0-0030606570 (Pubitemid 126590563)
5. Rabb H., O'Meara Y. M., Maderna P., Coleman P., Brady H. R., Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney International 1997 51 5 1463 1468 2-s2.0-0031004208 (Pubitemid 27239898)
6. Sheridan A. M., Bonventre J. V., Cell biology and molecular mechanisms of injury in ischemic acute renal failure. Current Opinion in Nephrology and Hypertension 2000 9 4 427 434 2-s2.0-0033936194 10.1097/00041552-200007000-00015 (Pubitemid 30451699)
7. Rao R. M., Yang L., Garcia-Cardena G., Luscinskas F. W., Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circulation Research 2007 101 3 234 247 2-s2.0-34548302084 10.1161/CIRCRESAHA. 107.151860b (Pubitemid 47344073)
8. Bonventre J. V., Zuk A., Ischemic acute renal failure: an inflammatory disease? Kidney International 2004 66 2 480 485 2-s2.0-3242772187 10.1111/j.1523-1755.2004.761-2.x (Pubitemid 38981982)
9. Friedewald J. J., Rabb H., Inflammatory cells in ischemic acute renal failure. Kidney International 2004 66 2 486 491 2-s2.0-3242806045 10.1111/j.1523-1755.2004.761-3.x (Pubitemid 38981983)
10. Ramesh G., Reeves W. B., Inflammatory cytokines in acute renal failure. Kidney International. Supplement 2004 66 91 S56 S61 2-s2.0-4644324913 (Pubitemid 39281716)
11. Kielar M. L., John R., Bennett M., Richardson J. A., Shelton J. M., Chen L., Jeyarajah D. R., Zhou X. J., Zhou H., Chiquett B., Nagami G. T., Lu C. Y., Maladaptive role of IL-6 in ischemic acute renal failure. Journal of the American Society of Nephrology 2005 16 11 3315 3325 2-s2.0-33644874979 10.1681/ASN.2003090757 (Pubitemid 46179335)
12. Simmons E. M., Himmelfarb J., Tugrul Sezer M., Chertow G. M., Mehta R. L., Paganini E. P., Soroko S., Freedman S., Becker K., Spratt D., Shyr Y., Alp Ikizler T., Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney International 2004 65 4 1357 1365 2-s2.0-12144289562 10.1111/j.1523-1755.2004.00512.x (Pubitemid 38406974)
13. Albelda S. M., Smith C. W., Ward P. A., Adhesion molecules and inflammatory injury. FASEB Journal 1994 8 8 504 512 2-s2.0-0028231065 (Pubitemid 24161123)
14. Fuggle S. V., Koo D. D. H., Cell adhesion molecules in clinical renal transplantation. Transplantation 1998 65 6 763 769 2-s2.0-0032571299 10.1097/00007890-199803270-00001 (Pubitemid 28160666)
15. Molitoris B. A., Marrs J., The role of cell adhesion molecules in ischemic acute renal failure. American Journal of Medicine 1999 106 5 583 592 2-s2.0-0033135667 10.1016/S0002-9343(99)00061-3 (Pubitemid 29231111)
16. Guijarro C., Egido J., Transcription factor- B (NF- B) and renal disease. Kidney International 2001 59 2 415 424 2-s2.0-0035137324 10.1046/j.1523-1755. 2001.059002415.x (Pubitemid 32157906)
17. Spandou E., Tsouchnikas I., Karkavelas G., Dounousi E., Simeonidou C., Guiba-Tziampiri O., Tsakiris D., Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrology Dialysis Transplantation 2006 21 2 330 336 2-s2.0-31544472841 10.1093/ndt/gfi177 (Pubitemid 43159985)
18. Cao C. C., Ding X. Q., Ou Z. L., Liu C. F., Peng L., Wang L., Zhu C. F., In vivo transfection of NF- B decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney International 2004 65 3 834 845 2-s2.0-1342280338 10.1111/j.1523-1755.2004.00463.x (Pubitemid 38251059)
19. Chen J., Gui D., Chen Y., Mou L., Liu Y., Huang J., Astragaloside IV improves high glucose-induced podocyte adhesion dysfunction via α 3 β 1 integrin upregulation and integrin-linked kinase inhibition. Biochemical Pharmacology 2008 76 6 796 804 2-s2.0-50649092654 10.1016/j.bcp.2008.06.020
20. Zhang W.-D., Chen H., Zhang C., Liu R.-H., Li H.-L., Chen H.-Z., Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro. Planta Medica 2006 72 1 4 8 2-s2.0-32644451004 10.1055/s-2005-873126 (Pubitemid 43241585)
21. Qu Y. Z., Li M., Zhao Y. L., Zhao Z. W., Wei X. Y., Liu J. P., Gao L., Gao G. D., Astragaloside IV attenuates cerebral ischemia-reperfusion-induced increase in permeability of the blood-brain barrier in rats. European Journal of Pharmacology 2009 606 1-3 137 141 2-s2.0-60949092865 10.1016/j.ejphar.2009.01. 022
22. Zhang W.-J., Hufnagl P., Binder B. R., Wojta J., Antiinflammatory activity of astragaloside IV is mediated by inhibition of NF- B activation and adhesion molecule expression. Thrombosis and Haemostasis 2003 90 5 904 914 2-s2.0-0242606426 (Pubitemid 37427861)
23. Du Q., Chen Z., Zhou L.-F., Zhang Q., Huang M., Yin K.-S., Inhibitory effects of astragaloside IV on ovalbumin-induced chronic experimental asthma. Canadian Journal of Physiology and Pharmacology 2008 86 7 449 457 2-s2.0-46749114754 10.1139/Y08-053 (Pubitemid 351948684)
24. Li M., Qu Y. Z., Zhao Z. W., Wu S. X., Liu Y. Y., Wei X. Y., Gao L., Gao G. D., Astragaloside IV protects against focal cerebral ischemia/reperfusion injury correlating to suppression of neutrophils adhesion-related molecules. Neurochemistry International 2012 60 5 458 465 2-s2.0-84857953412 10.1016/j.neuint.2012.01.026
25. Melnikov V. Y., Faubel S., Siegmund B., Scott Lucia M., Ljubanovic D., Edelstein C. L., Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice. The Journal of Clinical Investigation 2002 110 8 1083 1091 2-s2.0-0036800759 10.1172/JCI200215623 (Pubitemid 35215889)
26. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001 25 4 402 408 2-s2.0-0035710746 10.1006/meth.2001.1262 (Pubitemid 34164012)
27. Sung F. L., Zhu T. Y., Au-Yeung K. K. W., Siow Y. L., Karmin O., Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF- B. Kidney International 2002 62 4 1160 1170 2-s2.0-0036378606 10.1046/j.1523-1755.2002.00577.x
28. Baldwin A. S. Jr., Series introduction: the transcription factor NF-kappaB and human disease. The Journal of Clinical Investigation 2011 7 3 6
29. Barnes P. J., Karin M., Nuclear factor- B-a pivotal transcription factor in chronic inflammatory diseases. The New England Journal of Medicine 1997 336 15 1066 1071 2-s2.0-0030615201 10.1056/NEJM199704103361506 (Pubitemid 27163860)
30. Karin M., Lin A., NF- B at the crossroads of life and death. Nature Immunology 2002 3 3 221 227 2-s2.0-0036009115 10.1038/ni0302-221 (Pubitemid 34213423)
31. Pahl H. L., Activators and target genes of Rel/NF- B transcription factors. Oncogene 1999 18 49 6853 6866 2-s2.0-0033596121
32. Weih F., Caamaño J., Regulation of secondary lymphoid organ development by the nuclear factor- B signal transduction pathway. Immunological Reviews 2003 195 91 105 2-s2.0-0141567432 10.1034/j.1600-065X.2003.00064.x (Pubitemid 37153456)
33. Oliver K. M., Taylor C. T., Cummins E. P., Hypoxia. Regulation of NF B signalling during inflammation: the role of hydroxylases. Arthritis Research and Therapy 2009 11 1, article 215 2-s2.0-69249220253 10.1186/ar2575
34. Thurman J. M., Triggers of inflammation after renal ischemia/reperfusion. Clinical Immunology 2007 123 1 7 13 2-s2.0-33947108375 10.1016/j.clim.2006.09. 008 (Pubitemid 46401502)
35. Okazaki T., Sakon S., Sasazuki T., Sakurai H., Doi T., Yagita H., Okumura K., Nakano H., Phosphorylation of serine 276 is essential for p65 NF- B subunit-dependent cellular responses. Biochemical and Biophysical Research Communications 2003 300 4 807 812 2-s2.0-0037462880 10.1016/S0006-291X(02)02932- 7 (Pubitemid 36259833)
36. Matthijsen R. A., Huugen D., Hoebers N. T., De Vries B., Peutz-Kootstra C. J., Aratani Y., Daha M. R., Tervaert J. W. C., Buurman W. A., Heeringa P., Myeloperoxidase is critically involved in the induction of organ damage after renal ischemia reperfusion. American Journal of Pathology 2007 171 6 1743 1752 2-s2.0-38349000796 10.2353/ajpath.2007.070184
37. Bonventre J. V., Yang L., Cellular pathophysiology of ischemic acute kidney injury. The Journal of Clinical Investigation 2011 121 11 4210 4221 2-s2.0-80555157523 10.1172/JCI45161
38. Jo S.-K., Sung S.-A., Cho W.-Y., Go K.-J., Kim H.-K., Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrology Dialysis Transplantation 2006 21 5 1231 1239 2-s2.0-33646201785 10.1093/ndt/gfk047
39. Rezende-Neto J. B., Moore E. E., de Andrade M. V. M., Teixeira M. M., Assis Lisboa F., Esteves Arantes R. M., De Souza D. G., Da Cunha-Melo J. R., Systemic inflammatory response secondary to abdominal compartment syndrome: stage for multiple organ failure. The Journal of Trauma 2002 53 6 1121 1128 2-s2.0-0036898442 (Pubitemid 35435105)
40. Singbartl K., Ley K., Leukocyte recruitment and acute renal failure. Journal of Molecular Medicine 2004 82 2 91 101 2-s2.0-1542284509 10.1007/s00109-003-0498-8 (Pubitemid 38299708)
41. Phull H., Lien Y.-H. H., Salkini M. W., Escobar C., Lai L.-W., Ramakumar S., Delivery of intercellular adhesion molecule-1 antisense oligonucleotides using a topical hydrogel tissue sealant in a murine partial nephrectomy/ischemia model. Urology 2008 72 3 690 695 2-s2.0-50249132726 10.1016/j.urology.2007.12. 042
42. Star R. A., Treatment of acute renal failure. Kidney International 1998 54 6 1817 1831 2-s2.0-0031783727 10.1046/j.1523-1755.1998.00210.x (Pubitemid 28533609)
43. Donnahoo K. K., Meldrum D. R., Shenkar R., Chung C.-S., Abraham E., Harken A. H., Early renal ischemia, with or without reperfusion, activates NF B and increases TNF- α bioactivity in the kidney. Journal of Urology 2000 163 4 1328 1332 2-s2.0-0034108338 (Pubitemid 30169434)
44. Donnahoo K. K., Meng X., Ayala A., Cain M. P., Harken A. H., Meldrum D. R., Early kidney TNF- α expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. American Journal of Physiology 1999 277 3 R922 R929 2-s2.0-0032885441 (Pubitemid 29458168)
45. Kumar S., Allen D. A., Kieswich J. E., Patel N. S. A., Harwood S., Mazzon E., Cuzzocrea S., Raftery M. J., Thiemermann C., Yaqoob M. M., Dexamethasone ameliorates renal ischemia-reperfusion injury. Journal of the American Society of Nephrology 2009 20 11 2412 2425 2-s2.0-72049093258 10.1681/ASN.2008080868
46. Gui D., Huang J., Liu W., Guo Y., Xiao W., Wang N., Astragaloside IV prevents acute kidney injury in two rodent models by inhibiting oxidative stress and apoptosis pathways. Apoptosis 2013 18 4 409 422
47. Barrera-Chimal J., Pérez-Villalva R., Rodríguez-Romo R., Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury. Kidney International 2013 83 93 103
48. Yu Q.-C., Zhu T.-Y., Zhang Y.-K., Effect of astrgaloside IV on the long-term consequences of renal ischemia-reperfusion injury in rat. Zhonghua Yi Xue Za Zhi 2004 84 17 1412 1415 2-s2.0-23844484695
49. Gui D., Huang J., Guo Y., Astragaloside IV ameliorates renal injury in streptozotocin-induced diabetic rats through inhibiting NF- B-mediated inflammatory genes expression. Cytokine 2013 61 3 970 977
50. Gui D., Guo Y., Wang F., Astragaloside IV, a novel antioxidant, prevents glucose-induced podocyte apoptosis in vitro and in vivo. PLoS One 2012 7 6 e39824